CM Hospitalar S/A (BVMF:VVEO3)

Market Cap	322.12M +4.1%
Revenue (ttm)	11.71B +2.0%
Net Income	56.87M
EPS	0.18
Shares Out	315.81M
PE Ratio	5.66
Forward PE	14.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,741,100
Open	0.980
Previous Close	0.960
Day's Range	0.950 - 1.030
52-Week Range	0.560 - 1.860
Beta	0.62
Analysts	Sell
Price Target	1.22 (+19.61%)
Earnings Date	Nov 10, 2026

About CM Hospitalar S/A

CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers material products for cardiac, surgical, urinary, diagnosis, sterilization, wound management, hygiene and protection, infusion, clinical nutrition, orthopedic, and respiratory; and medications, such as painkillers, anesthetics, anti-allergy, antibiotics, antiemetics, antifungals, anti-inflammatory, special control, several, and oncology. It also provides materials for respiratory assistance, therapy, anti-inflamma...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2010
• Employees: 6,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: VVEO3

Analyst Summary

According to 5 analysts, the average rating for VVEO3 stock is "Sell." The 12-month stock price target is R$1.22, which is an increase of 19.61% from the latest price.

Price Target

R$1.22

(19.61% upside)

Analyst Consensus: Sell

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 16, 2026

Data Sources Report a data error